We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Variant-Specific Viral Kinetics in Acute COVID-19.
- Authors
Ribeiro, Ruy M; Choudhary, Manish C; Deo, Rinki; Giganti, Mark J; Moser, Carlee; Ritz, Justin; Greninger, Alexander L; Regan, James; Flynn, James P; Wohl, David A; Currier, Judith S; Eron, Joseph J; Hughes, Michael D; Smith, Davey M; Chew, Kara W; Daar, Eric S; Perelson, Alan S; Li, Jonathan Z; Team, for the ACTIV-2/A5401 Study
- Abstract
Understanding variant-specific differences in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral kinetics may explain differences in transmission efficiency and provide insights on pathogenesis and prevention. We evaluated SARS-CoV-2 kinetics from nasal swabs across multiple variants (Alpha, Delta, Epsilon, Gamma) in placebo recipients of the ACTIV-2/A5401 trial. Delta variant infection led to the highest maximum viral load and shortest time from symptom onset to viral load peak. There were no significant differences in time to viral clearance across the variants. Viral decline was biphasic with first- and second-phase decays having half-lives of 11 hours and 2.5 days, respectively, with differences among variants, especially in the second phase. These results suggest that while variant-specific differences in viral kinetics exist, post–peak viral load all variants appeared to be efficiently cleared by the host. Clinical Trials Registration. NCT04518410.
- Subjects
SARS-CoV-2; SARS-CoV-2 Delta variant; CLINICAL trial registries; COVID-19
- Publication
Journal of Infectious Diseases, 2023, Vol 288, pS136
- ISSN
0022-1899
- Publication type
Article
- DOI
10.1093/infdis/jiad314